Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2673

PDF: 1389
Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan

26-06-2025

https://doi.org/10.4081/reumatismo.2025.1792

1001

PDF: 160
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

24-30

01-04-2019

https://doi.org/10.4081/reumatismo.2019.1154

1583

PDF: 1107
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1608

1523

PDF: 565
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1544

1094

PDF: 575
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1831

PDF: 456
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1559

1682

PDF: 913
Long-term survival of methotrexate in psoriatic arthritis

M. Ricci, G. De Marco, F. Desiati, D. Mazzocchi, L. Rotunno, N. Battafarano, A. Marchesoni

125-131

https://doi.org/10.4081/reumatismo.2009.125

1213

PDF: 900
Biologic therapy with anti-TNFa in rheumathoid atrhritis

G. Ferraccioli

17-21

https://doi.org/10.4081/reumatismo.2005.4s.17

758

PDF: 684
The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

M. Varenna, D. Gatti

163-171

https://doi.org/10.4081/reumatismo.2010.163

1778

PDF: 1211

1 - 10 of 10 items

Search

Search Results

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

Long-term survival of methotrexate in psoriatic arthritis

Biologic therapy with anti-TNFa in rheumathoid atrhritis

The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

authors

reviewers

Categories

indexing

Keywords